Regulatory compliance - August 22, 2014
Novo Nordisk accepts fine
The company has announced that it accepts fine for violating disclosure obligation in Denmark. Novo Nordisk A/S has accepted a DKK 500,000 fine imposed by the Public Prosecutor in a suit filed by the Danish Financial Supervisory Authority. In December 2013, the Danish Financial Supervisory Authority reported the company to the police for violating its obligation under […]
Acquisition - August 22, 2014
Pfizer could set eyes on AstraZeneca again
Pfizer could still be interested in buying AstraZeneca, reports Bloomberg refering to individuals with insight into the matter. Pfizer may not get a great shot at buying AstraZeneca this fall but it’s however preparing to give it a try. Meanwhile, Bloomberg reports, the U.S.-based drug giant is looking at Actavis among other targets. The Pfizer management […]
Collaboration - August 21, 2014
AstraZeneca in partnership with Illumina
AstraZeneca has entered into a collaboration with gene sequencing company, Illumina, Inc., to develop its next generation sequencing (NGS) platform for companion diagnostic tests. In the first instance, AstraZeneca intends to apply Illumina’s technology to a novel companion diagnostic test in pivotal studies for one of its investigational oncology compounds. This is expected to be […]
Financing - August 20, 2014
Vigmed sets eyes on Nasdaq OMX Small Cap
The board of Vigmed has initiated a process to prepare the company for a change of venue for the company’s shares from NASDAQ OMX First North to NASDAQ OMX Stockholm Small Cap. Vigmed states that it is a natural step considering the anticipated growth linked to the fact that the company now has started selling its […]
Science Award - August 20, 2014
Award to Uppsala researcher and surgeon
Tomas Lorant, transplantation surgeon at Akademiska sjukhuset, Uppsala University Hospital, and researcher at Uppsala University, has received the Swedish Surgical Society’s research prize of 2014. He is given the award for his work in translational research within the area of transplantation. Lorant has conducted clinical studies in immunological risk assesment of kidney transplanted patients and […]
Acquisition - August 19, 2014
Recipharm acquires Corvette Pharmaceutical Services Group
The Swedish contract development and manufacturing organisation Recipharm has signed an agreement to acquire Milan based Corvette Pharmaceutical Services Group for SEK 1.1 billion. The sellers of Corvette Group are LBO Italia Investimenti Srl (“LBO Italia”), as controlling shareholder, and some private investors, holding minority interests. Corvette Pharmaceutical Services Group (consisting of Corvette Group SpA and […]
